Kenro Hirata

2.3k total citations
101 papers, 1.8k citations indexed

About

Kenro Hirata is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kenro Hirata has authored 101 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 37 papers in Pulmonary and Respiratory Medicine and 37 papers in Oncology. Recurrent topics in Kenro Hirata's work include Gastric Cancer Management and Outcomes (29 papers), Helicobacter pylori-related gastroenterology studies (23 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Kenro Hirata is often cited by papers focused on Gastric Cancer Management and Outcomes (29 papers), Helicobacter pylori-related gastroenterology studies (23 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Kenro Hirata collaborates with scholars based in Japan, United States and Belgium. Kenro Hirata's co-authors include Juntaro Matsuzaki, Toshifumi Hibi∥, Hitoshi Tsugawa, Hidekazu Suzuki, Yoshimasa Saito, Hideyuki Saya, Toshihiro Nishizawa, Osamu Nagano, Yoshikazu Kuroda and Hidekazu Suzuki and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kenro Hirata

90 papers receiving 1.8k citations

Peers

Kenro Hirata

SURGE

ONCOL

PRM

GASTR

Jan Bornschein Germany

Moriya Iwaizumi Japan

Chien‐Yu Lu Taiwan

K Okita Japan

Emilia Saraga Switzerland

Jae J. Kim South Korea

Masahide Ebi Japan

Takao Maekita Japan

Shudong Xiao China

Mikihiro Fujiya Japan

Jan Bornschein Germany

Kenro Hirata

923 ×0.9

SURGE

410 ×0.9

ONCOL

524 ×1.2

PRM

532 ×1.2

203 ×0.6

GASTR

Citations per year, relative to Kenro Hirata Kenro Hirata (= 1×) peers Jan Bornschein

Countries citing papers authored by Kenro Hirata

Since Specialization

Citations

This map shows the geographic impact of Kenro Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenro Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenro Hirata more than expected).

Fields of papers citing papers by Kenro Hirata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenro Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenro Hirata. The network helps show where Kenro Hirata may publish in the future.

Co-authorship network of co-authors of Kenro Hirata

This figure shows the co-authorship network connecting the top 25 collaborators of Kenro Hirata. A scholar is included among the top collaborators of Kenro Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenro Hirata. Kenro Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirata, Kenro, et al.. (2026). Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan. EClinicalMedicine. 92. 103768–103768.

Mizuno, Koji, et al.. (2026). Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors. Nature Medicine. 32(2). 690–701.

Kawakami, Hisato, Shigenori Kadowaki, Akitaka Makiyama, et al.. (2025). Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer. Journal of Clinical Oncology. 43(19). 2184–2195. 2 indexed citations

Yamamoto, Shun, Satoru Matsuda, Takahiro Tsushima, et al.. (2025). Phase II study of neoadjuvant chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel for resectable esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 43(4_suppl). 418–418.

Kawasaki, Kenta, Hideyuki Hayashi, S. Shimizu, et al.. (2024). Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia. Oncology Letters. 28(6). 568–568. 1 indexed citations

Muro, Kei, Hisato Kawakami, Shigenori Kadowaki, et al.. (2023). 1513MO A phase II study of nivolumab plus low dose ipilimumab as first -line therapy in patients with advanced gastric or esophago-gastric junction MSI-H tumor: First results of the NO LIMIT study (WJOG13320G/CA209-7W7). Annals of Oncology. 34. S852–S853. 10 indexed citations

Kawakami, Hisato, Shuichi Hironaka, Taito Esaki, et al.. (2021). An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7). Cancers. 13(4). 805–805. 14 indexed citations

Shimozaki, Keitaro, Yasutaka Sukawa, Yasunori Sato, et al.. (2021). Analysis of Risk Factors for Immune-Related Adverse Events in Various Solid Tumors Using Real-World Data. Future Oncology. 17(20). 2593–2603. 16 indexed citations

Shimozaki, Keitaro, Kenro Hirata, Yukie Hayashi, et al.. (2021). The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study. Diagnostics. 11(3). 543–543. 2 indexed citations

10.

Hayashi, Yukie, Naoki Hosoe, Kaoru Takabayashi, et al.. (2020). Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis. Digestive Diseases and Sciences. 66(6). 2129–2134. 28 indexed citations

11.

Hirata, Kenro, Yasuo Hamamoto, Masahiko Ando, et al.. (2020). Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group. BMC Cancer. 20(1). 548–548. 9 indexed citations

12.

Shimozaki, Keitaro, Yasutaka Sukawa, Isao Kurihara, et al.. (2020). <p>Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors</p>. Cancer Management and Research. Volume 12. 4585–4593. 57 indexed citations

13.

Kasuga, Akiyoshi, Yasuo Hamamoto, Ayano Takeuchi, et al.. (2017). Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy. Cancer Chemotherapy and Pharmacology. 79(3). 595–602. 13 indexed citations

14.

Matsuda, Takeru, Kenro Hirata, Daisuke Tsugawa, et al.. (2015). A Simple and Reliable Method for Intracorporeal Circular-Stapled Esophagojejunostomy Using a Hand-Sewn Over-and-Over Suture Technique in Laparoscopic Total Gastrectomy. Annals of Surgical Oncology. 22(S3). 355–355. 1 indexed citations

15.

Matsuda, Takeru, Kenro Hirata, Daisuke Tsugawa, et al.. (2015). A Three-Step Method for Laparoscopic Mobilization of the Splenic Flexure. Annals of Surgical Oncology. 22(S3). 335–335. 6 indexed citations

16.

Suzuki, Hidekazu, et al.. (2013). Validation of the GerdQ questionnaire for the management of gastro‐oesophageal reflux disease in Japan. United European Gastroenterology Journal. 1(3). 175–183. 59 indexed citations

17.

Urade, Takeshi, et al.. (2012). Eosinophilic gastroenteritis associated with multiple gastric cancer. European Journal of Gastroenterology & Hepatology. 24(6). 727–730. 7 indexed citations

18.

Tsugawa, Hitoshi, Hidekazu Suzuki, Hideyuki Saya, et al.. (2012). Reactive Oxygen Species-Induced Autophagic Degradation of Helicobacter pylori CagA Is Specifically Suppressed in Cancer Stem-like Cells. Cell Host & Microbe. 12(6). 764–777. 180 indexed citations

19.

Tsugawa, Hitoshi, Hidekazu Suzuki, Kazue Satoh, et al.. (2010). Two Amino Acids Mutation of Ferric Uptake Regulator Determines Helicobacter pylori Resistance to Metronidazole. Antioxidants and Redox Signaling. 14(1). 15–23. 52 indexed citations

20.

Matsuzaki, Juntaro, Hidekazu Suzuki, Keiko Asakura, et al.. (2010). Etiological difference between ultrashort- and short-segment Barrett’s esophagus. Journal of Gastroenterology. 46(3). 332–338. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact